14-day Premium Trial Subscription Try For FreeTry Free
$4.71
+0.0250 (+0.534%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $4.06 $5.34 Friday, 3rd May 2024 SVRA stock ended at $4.71. This is 0.534% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.33% from a day low at $4.66 to a day high of $4.81.
90 days $4.06 $5.70
52 weeks $1.83 $5.70

Historical Savara Inc prices

Date Open High Low Close Volume
May 23, 2016 $0.310 $0.310 $0.300 $0.308 1 359 874
May 20, 2016 $0.295 $0.310 $0.295 $0.300 1 836 595
May 19, 2016 $0.310 $0.310 $0.285 $0.300 1 582 368
May 18, 2016 $0.300 $0.310 $0.297 $0.305 1 400 892
May 17, 2016 $0.316 $0.317 $0.298 $0.300 1 712 250
May 16, 2016 $0.310 $0.320 $0.297 $0.312 2 235 801
May 13, 2016 $0.310 $0.318 $0.293 $0.296 1 729 487
May 12, 2016 $0.320 $0.330 $0.303 $0.303 1 460 883
May 11, 2016 $0.320 $0.324 $0.310 $0.320 708 633
May 10, 2016 $0.310 $0.320 $0.305 $0.316 1 665 134
May 09, 2016 $0.305 $0.326 $0.300 $0.315 1 511 693
May 06, 2016 $0.323 $0.335 $0.315 $0.317 1 366 816
May 05, 2016 $0.337 $0.337 $0.316 $0.319 870 632
May 04, 2016 $0.330 $0.340 $0.314 $0.330 3 163 268
May 03, 2016 $0.295 $0.330 $0.290 $0.319 2 495 335
May 02, 2016 $0.300 $0.300 $0.289 $0.290 763 757
Apr 29, 2016 $0.290 $0.310 $0.290 $0.295 1 161 768
Apr 28, 2016 $0.320 $0.320 $0.290 $0.301 1 600 017
Apr 27, 2016 $0.318 $0.320 $0.302 $0.310 558 822
Apr 26, 2016 $0.331 $0.331 $0.305 $0.314 1 233 211
Apr 25, 2016 $0.328 $0.330 $0.320 $0.320 847 916
Apr 22, 2016 $0.330 $0.338 $0.320 $0.320 668 313
Apr 21, 2016 $0.330 $0.340 $0.314 $0.330 903 894
Apr 20, 2016 $0.340 $0.340 $0.312 $0.330 1 457 431
Apr 19, 2016 $0.360 $0.370 $0.327 $0.327 2 534 479
Click to get the best stock tips daily for free!

About Savara Inc

Savara Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.... SVRA Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT